通过残留物H524/L525的突变改变雌激素受体α联结域的选择性变化
Emma L Arévalo-Salina1, Takuya Nishigaki2, Leticia Olvera1
1Departamento de Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos 62210, Mexico.
Biochimica et biophysica acta. General subjects
|February 16, 2025
概括
研究人员设计了雌激素受体α (ERα) 变体,提高了乳腺癌药物内西芬的选择性. 这项工作推进了用于内分泌毒素生物传感器的选择性分子开发.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 雌激素受体α (ERα) 有一个大,适应性的连接体结合口袋.
- 与ERα结合的联体诱导着形状变化,影响细胞反应和蛋白质相互作用.
- 结合体结合域的修饰可以改变ERα对激素激剂和抗剂的选择性.
研究的目的:
- 为了设计具有改变带结合性质的ERα变体.
- 为了研究特定残留物在ERα的连接体选择性中的作用.
- 开发一种乳腺癌治疗药物 - - 内西芬 - - 的改进识别分子.
主要方法:
- 通过修改残留524和525来设计了一个ERα变体库.
- 评估了这些变体对各种配体的选择性,包括内西芬,4-OHT和雌激素.
- 分析了工程突变的结构和功能影响.
主要成果:
- 埃尔α变异对抗剂内西芬具有显著增加的选择性 (高达70倍).
- 此外,这些变体对抗剂4-胺 (4-OHT) 的选择性也比雌激素更强 (高达50倍).
- 524和525的残留物被确定为ERα对雌激醇特异性的关键决定因素.
结论:
- 在ERα中特定的氨基酸替代可以大大提高对关键对手的选择性.
- 这些工程ERα变体是了解体受体相互作用的宝贵工具.
- 这些发现为开发针对性生物传感器为乳腺癌治疗中的内西芬铺平了道路.
相关概念视频
Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Internal Receptors
69.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.3K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K


